Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: dermal

Currently viewing:

Administrative data

acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1991-08-20 to 1991-09-17
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Minor deviations: - According to the guideline, a limit test of at least 2000 mg/kg bw can be carried out. In this study one additional concentration above the limit dose was also tested. - According to the guideline, the individual weights should be determined before the application of the test substance , which was done in this study. The individual weights were not provided in the report but only the average weight of the males and females per dose. - The guideline suggested that the rats should be in the weight range of 200 to 300 g at the beginning of the study but in this study the rats were in the weight range of 166 -181 g. - According to the guideline, the rats should be housed indivdually. In this study they were housed in groups of two or three rats. - According to the guideline the relative humidity should be between 30 - 70 %. In this study the relative humidity was slightly higher (60 +/- 20 %). - According to the guideline, the test substance should be applied to the skin. In this study the test substance was applied first to the patch and the patch was placed onto the skin.

Data source

Reference Type:
study report
Report date:

Materials and methods

Test guideline
according to guideline
OECD Guideline 402 (Acute Dermal Toxicity)
Version / remarks:
see rational for reliability
GLP compliance:
yes (incl. QA statement)
The study states that the study was performed according to eg. "Good Laboratory Practice" Regulations of the EEC enacted in Germany in the "Chemikaliengesetz" dated March 14 th, 1990, BGBL.I, pp. 521, 1990.
Test type:
standard acute method
Limit test:

Test material

Constituent 1
Chemical structure
Reference substance name:
Divanadium pentaoxide
EC Number:
EC Name:
Divanadium pentaoxide
Cas Number:
Molecular formula:
divanadium pentaoxide
Test material form:
solid: particulate/powder
Details on test material:
- Name of test material (as cited in study report): Divanadium pentaoxide (V2O5) analytical grade pulverised
- Physical state: beige, solid (powder)
- Stability under test conditions: stable during the course of the study
- Storage condition of test material: dry, in closed container at room temperature
- Median particle size: 3.0 - 3.9 µm

Test animals

Details on test animals or test system and environmental conditions:
- Source: Lippische Versuchstierzucht HAGEMANN GmbH, D- 4923 Extertal 1
- Age at study initiation: approx. 40 - 60 days
- Weight at study initiation: 166 - 181 g
- Fasting period before study: approx. 16 hours
- Housing: Animals were kept in groups of two or three in MAKROLON cages (type III). Gradulated textured wood was used as bedding material (Granulat Typ A2, supplier: Messrs. BRANDENBURG, Inh. H.Brandenburg, D-2849 Goldenstedt)
- Diet: Standardized diet for rats ALTROMIN 1324 (supplied by: ALTROMIN GmbH, D-4937 LAge/Lippe)
- Water (ad libitum): tap water
- Quarantine period: at least 5 days

- Temperature: 22 °C +/- 3 °C (maximum range)
- Relative humidity: 60 % +/- 20 % (maximum range)
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Type of coverage:
other: hydroxypropyl-methylcellulose
Details on dermal exposure:
The test substance was applied on the shaved intact dorsal skin of rats (5 X 6 cm, 1/10 of body surface). The hair on the site of application was clipped with hair-clippers without causing injury approximately 24 hours before application. The site was situated on the animal's back between the fore and hind extremeties and had an area of approx. 5 X 6 cm.
The test substance was applied to 8 layers of gauze and to the application site. The patch was covered with a plastic sheet and secured with adhesive plaster.

- Time after start of exposure: At the end of the exposure period, residual substance was removed with tepid tap water.

- Amount(s) applied (volume or weight with unit): The volume of application was 20 ml/kg b.w.. The dose interval factor was 1.25.

0.8 % aqueous hydroxypropyl-methylcellulose gel (Methocel E 4 M) served as vehicle for V2O5 analytical grade pulverised.
Batch No.(Vehicle): MM 84097413
Duration of exposure:
24 hours
2000, 2500 mg V2O5 analytical grade pulverised/kg b.w.
No. of animals per sex per dose:
5 males /5 females
Control animals:
not specified
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Observations were performed immediatly, 5, 15, 30 and 60 min, as well as 3 h, 6 h and 24 h after administration. During the follow-up period changes in skin and fur, eyes and mucous membranes, and the respiratory, circulatory, autonomic and central nervous system and somatomotor activity and behaviour pattern were observed at least once a day until all symptoms have subsided, thereafter each working day. Attention was also paid to possible tremors, convulsions, salivation, diarrhoea, lethargy, sleep and coma. Observations on mortality were made at least once daily with appropriate actions taken to minimise loss of animals during the study.
Individual body weights were recorded before administration of the substance, thereafter in weekly intervals up to the end of the study, and at death.
- Necropsy of survivors performed: yes, at the end of the experiments all surviving animals were sacrificed, dissected and inspected macroscopically. All gross pathological changes were recorded. From animals which survive 24 hours or longer a microscoic examination of all organs which show evident lesions was performed. Autopsy and macroscopic inspection of the animals which died prematurely were carried out as soon as possible after exitus.
- Other examinations performed: Changes in weight were calculated and recorded when survival exceeds one day. The skin was observed for the development of erythema and oedema and was rated as follows:
0 = no erythema
1 = very slight erythema (barely perceptible)
2 = well-defined erythema
3 = moderate to severe erythema
4 = severe erythemy (beet redness) to slight eschar formation (injuries in depth)
0 = no oedema
1 = very slight oedema (barely perceptible)
2 = slight oedema (edges of area well defined by definite raising)
3 = moderate oedema (raised approx. 1 mm)
4 = severe oedema (raised more than 1 mm and extending beyond the area of exposure)
The LD50 could not be calculated because none of the animals died prematurely.

Results and discussion

Effect levelsopen allclose all
Dose descriptor:
Effect level:
> 2 500 mg/kg bw
Dose descriptor:
Effect level:
> 2 500 mg/kg bw
None of the animals died prematurely.
Clinical signs:
other: Under the present test conditions no local or systemic intolerance reactions were observed up to the highest testd dose-level of 2500 mg V2O5 analytical grade pulverised /kg b.w. by dermal administration to rats.
Gross pathology:
No pathological findings

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
LD50 (rats) > 2500 mg/kg bw
According to the EC-Regulation 1272/2008 and subsequent regulations, the test item is not classified as acute toxic via the dermal route.